Comparative evolutionary pharmacogenomics of human prostaglandin-endoperoxide synthase paralogs identifies population-structured coding variation and protein-contextual candidates in N-terminal leader-sequence and catalytic-channel regions.
Authors
-
Dr. Reuben Maghembe on this scholarly contribution!
Abstract
The study provides an integrative computational pharmacogenomics analysis of PTGS1 and PTGS2 (COX-1 and COX-2), combining population genetics, transcript-aware variant annotation, protein topology, splice-prediction evidence, structural modelling and molecular docking.
Among its key findings, the study identifies distinct classes of population-structured variants and highlights PTGS1 N-terminal leader-sequence variants and PTGS2 p.Val511Ala as candidates for further functional and pharmacogenomic investigation. Importantly, the authors emphasize that these computational findings represent testable hypotheses rather than demonstrated clinical or functional effects.
Summary as published by the college when announcing this work. See the journal article for the full abstract.
More from Directorate of Research, Partnerships and Community Services
Invasive Non-Typhoidal Salmonella Disease in the Vaccine-Development Era: Diagnostic Blind Spots, Antimicrobial Resistance, Genomic Transmission, and Prevention
Dr. Reuben Maghembe, Samweli Bahati
Community screening findings: elevated blood pressure, obesity and selected health conditions among attendees in Ifakara, Tanzania.
Dr. Erick Filbert Luta, Jovin Tibenderana, Alberto Alexander, Kabika Jiabo, Yusufu Simra, Dr. Claus Thomas
Microbiome-Endocannabinoidome Crosstalk as an Immunometabolic Rheostat in Inflammatory Disease
Dr. Reuben Maghembe